Remove 2026 Remove Drug Development Remove Drug Research Remove Therapies
article thumbnail

Article EMA Thank You What will the orphan drug market exclusivity haircut mean for industry?

Agency IQ

The problems: Although the current regulation stimulated orphan drug research, it didn’t do enough The regulation fostered development of medicines for rare diseases since implementation, but not enough. High-priced cell and gene therapies are being increasingly developed for rare diseases.